Pharmaceutical Preparations · DE · CIK 1549595
Nurix Therapeutics discovers, develops, and commercializes targeted protein degradation medicines for cancer and inflammatory diseases
Comparable business profile · signals at a glance
Coverage (30d): 4 reputable articles · skews ▲ positive.
Reputable outlets only (Reuters, WSJ, CNBC, Barron's, and peers). More on Google News ↗
In the 90 days to Mar 2, 2026: 3 sold $715K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 2, 2026 | Ring ChristineChief Legal Officer | Sell | 8,148 | $15.44 | $126K |
| Feb 9, 2026 | Ring ChristineChief Legal Officer | Sell | 14,261 | $16.66 | $238K |
| Jan 30, 2026 | Hansen GwennChief Scientific Officer | Sell | 4,797 | $16.58 | $80K |
| Jan 30, 2026 |
| Ring ChristineChief Legal Officer |
| Sell |
| 4,333 |
| $16.58 |
| $72K |
| Jan 30, 2026 | Van Houte HansChief Financial Officer | Sell | 3,588 | $16.58 | $59K |
| Jan 30, 2026 | Hansen GwennChief Scientific Officer | Sell | 98 | $17.37 | $2K |
| Jan 30, 2026 | Ring ChristineChief Legal Officer | Sell | 88 | $17.37 | $2K |
| Jan 30, 2026 | Van Houte HansChief Financial Officer | Sell | 73 | $17.37 | $1K |
| Jan 20, 2026 | Ring ChristineChief Legal Officer | Sell | 3,760 | $18.42 | $69K |
| Dec 18, 2025 | Ring ChristineChief Legal Officer | Sell | 3,560 | $17.87 | $64K |
| Dec 18, 2025 | Ring ChristineChief Legal Officer | Sell | 200 | $18.56 | $4K |
| Nov 24, 2025 | Ring ChristineChief Legal Officer | Sell | 37,600 | $17.07 | $642K |
| Nov 3, 2025 | Van Houte HansChief Financial Officer | Sell | 6,284 | $12.56 | $79K |
| Oct 30, 2025 | Hansen GwennChief Scientific Officer | Sell | 4,087 | $12.80 | $52K |
| Oct 30, 2025 | Ring ChristineChief Legal Officer | Sell | 3,644 | $12.80 | $47K |
| Oct 30, 2025 | Van Houte HansChief Financial Officer | Sell | 3,130 | $12.80 | $40K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.